Australis Capital Inc. (AUSAF)

Market Cap	25.42K -99.8%
Revenue (ttm)	7.59M +1,221.1%
Net Income	-40.12M
EPS	-0.16
Shares Out	254.22M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	90,656
Average Volume	19,012
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	n/a
Beta	3,165.86
RSI	48.78
Earnings Date	n/a

About Australis Capital

Australis Capital Inc. operates as a cannabis company in the United States and internationally. The company was incorporated in 2018 and is based in Las Vegas, Nevada.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2018
• Country: Canada
• Stock Exchange: OTCMKTS
• Ticker Symbol: AUSAF

Financial Performance

In fiscal year 2022, Australis Capital's revenue was 9.47 million, an increase of 1221.13% compared to the previous year's 717,151. Losses were -50.09 million, 98.3% more than in 2021.

Financial numbers in CAD